Park Place Capital Corp Exact Sciences Corp Transaction History

Park Place Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$65.94 - $99.04 $6,000 - $9,012	91 Added 24.59%	461 $31,000
Q2 2023 Aug 04, 2023	SELL	$62.68 - $95.05 $376 - $570	-6 Reduced 1.6%	370 $34,000
Q1 2023 May 02, 2023	BUY	$47.19 - $70.77 $11,608 - $17,409	246 Added 189.23%	376 $25,000
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $3,945 - $6,909	130 New	130 $6,000

667

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.91B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Park Place Capital Corp with notifications on news.